An examination of the pharmacological impact of FOXO3a in breast cancer chemotherapy drugs, as well as its potential to argue the capacity of anticancer medications to trigger tumor cell apoptosis, will offer a novel approach to cure breast cancer. This evidence concerns the gene FOXO3 and breast carcinoma.